250 related articles for article (PubMed ID: 26216516)
1. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
[TBL] [Abstract][Full Text] [Related]
2. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
[TBL] [Abstract][Full Text] [Related]
3. Essential role of the N-terminal region of TFII-I in viability and behavior.
Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
[TBL] [Abstract][Full Text] [Related]
4. Consistent hypersocial behavior in mice carrying a deletion of
Martin LA; Iceberg E; Allaf G
Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
[TBL] [Abstract][Full Text] [Related]
5. Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome.
Borralleras C; Mato S; Amédée T; Matute C; Mulle C; Pérez-Jurado LA; Campuzano V
Mol Brain; 2016 Aug; 9(1):76. PubMed ID: 27485321
[TBL] [Abstract][Full Text] [Related]
6. Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.
Antonell A; Del Campo M; Magano LF; Kaufmann L; de la Iglesia JM; Gallastegui F; Flores R; Schweigmann U; Fauth C; Kotzot D; Pérez-Jurado LA
J Med Genet; 2010 May; 47(5):312-20. PubMed ID: 19897463
[TBL] [Abstract][Full Text] [Related]
7. The contribution of GTF2I haploinsufficiency to Williams syndrome.
Chailangkarn T; Noree C; Muotri AR
Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
[TBL] [Abstract][Full Text] [Related]
8. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Barak B; Zhang Z; Liu Y; Nir A; Trangle SS; Ennis M; Levandowski KM; Wang D; Quast K; Boulting GL; Li Y; Bayarsaihan D; He Z; Feng G
Nat Neurosci; 2019 May; 22(5):700-708. PubMed ID: 31011227
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons.
Cavallo F; Troglio F; Fagà G; Fancelli D; Shyti R; Trattaro S; Zanella M; D'Agostino G; Hughes JM; Cera MR; Pasi M; Gabriele M; Lazzarin M; Mihailovich M; Kooy F; Rosa A; Mercurio C; Varasi M; Testa G
Mol Autism; 2020 Nov; 11(1):88. PubMed ID: 33208191
[TBL] [Abstract][Full Text] [Related]
10. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.
Enkhmandakh B; Makeyev AV; Erdenechimeg L; Ruddle FH; Chimge NO; Tussie-Luna MI; Roy AL; Bayarsaihan D
Proc Natl Acad Sci U S A; 2009 Jan; 106(1):181-6. PubMed ID: 19109438
[TBL] [Abstract][Full Text] [Related]
11. A duplicated gene in the breakpoint regions of the 7q11.23 Williams-Beuren syndrome deletion encodes the initiator binding protein TFII-I and BAP-135, a phosphorylation target of BTK.
Pérez Jurado LA; Wang YK; Peoples R; Coloma A; Cruces J; Francke U
Hum Mol Genet; 1998 Mar; 7(3):325-34. PubMed ID: 9466987
[TBL] [Abstract][Full Text] [Related]
12. The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.
Vandeweyer G; Van der Aa N; Reyniers E; Kooy RF
Am J Hum Genet; 2012 Jun; 90(6):1071-8. PubMed ID: 22608712
[TBL] [Abstract][Full Text] [Related]
13. Anxious, hypoactive phenotype combined with motor deficits in Gtf2ird1 null mouse model relevant to Williams syndrome.
Schneider T; Skitt Z; Liu Y; Deacon RM; Flint J; Karmiloff-Smith A; Rawlins JN; Tassabehji M
Behav Brain Res; 2012 Aug; 233(2):458-73. PubMed ID: 22652393
[TBL] [Abstract][Full Text] [Related]
14. A role for transcription factor GTF2IRD2 in executive function in Williams-Beuren syndrome.
Porter MA; Dobson-Stone C; Kwok JB; Schofield PR; Beckett W; Tassabehji M
PLoS One; 2012; 7(10):e47457. PubMed ID: 23118870
[TBL] [Abstract][Full Text] [Related]
15. Gtf2i and Gtf2ird1 mutation do not account for the full phenotypic effect of the Williams syndrome critical region in mouse models.
Kopp N; McCullough K; Maloney SE; Dougherty JD
Hum Mol Genet; 2019 Oct; 28(20):3443-3465. PubMed ID: 31418010
[TBL] [Abstract][Full Text] [Related]
16. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
Crespi BJ; Hurd PL
BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
[TBL] [Abstract][Full Text] [Related]
17. A mouse single-copy gene, Gtf2i, the homolog of human GTF2I, that is duplicated in the Williams-Beuren syndrome deletion region.
Wang YK; Pérez-Jurado LA; Francke U
Genomics; 1998 Mar; 48(2):163-70. PubMed ID: 9521869
[TBL] [Abstract][Full Text] [Related]
18. An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient.
Ferrero GB; Howald C; Micale L; Biamino E; Augello B; Fusco C; Turturo MG; Forzano S; Reymond A; Merla G
Eur J Hum Genet; 2010 Jan; 18(1):33-8. PubMed ID: 19568270
[TBL] [Abstract][Full Text] [Related]
19. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.
Morris CA; Mervis CB; Hobart HH; Gregg RG; Bertrand J; Ensing GJ; Sommer A; Moore CA; Hopkin RJ; Spallone PA; Keating MT; Osborne L; Kimberley KW; Stock AD
Am J Med Genet A; 2003 Nov; 123A(1):45-59. PubMed ID: 14556246
[TBL] [Abstract][Full Text] [Related]
20. Atypical 7q11.23 deletions excluding ELN gene result in Williams-Beuren syndrome craniofacial features and neurocognitive profile.
Alesi V; Loddo S; Orlando V; Genovese S; Di Tommaso S; Liambo MT; Pompili D; Ferretti D; Calacci C; Catino G; Falasca R; Dentici ML; Novelli A; Digilio MC; Dallapiccola B
Am J Med Genet A; 2021 Jan; 185(1):242-249. PubMed ID: 33098373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
